10 Nugent Road
Guildford, Surrey, GU2 7AF England
While most of the industry is dipping its toes into stem cell research, ReNeuron is swimming in the deep end of the research pool. The firm specializes in stem cell research and development focused on therapies for neurodegenerative and other diseases. Its lead product, ReN001, is in phase 3 development as a stroke treatment. Other candidates include ReN009 as a treatment for peripheral arterial disease, and ReN003 for blindness caused by retinal disease. ReN003 is being developed with
† Some telephone numbers on the Hoover’s site may be on a country’s do not call or do not contact list including, but not limited to, the United Kingdom’s CTPS or TPS registers. It is a legal requirement that companies do not make sales or marketing calls to registered numbers. These are central opt out registers whereby corporate subscribers and individuals can register their preference not to receive unsolicited sales and marketing telephone calls. By using the information provided on the Hoover’s sites, as the direct marketer you represent and warrant that you will use such information in compliance with all applicable local, state, national or international laws and regulations, including any local do not call registers or marketing regulations, and agree to defend, indemnify and hold harmless Dun & Bradstreet and each of its affiliates in the event your use violates such laws and regulations.